Evaluation of Prolonged Apnea Supported by High Frequency Non-invasive Ventilation.

NCT ID: NCT02712190

Last Updated: 2020-08-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-03-31

Study Completion Date

2022-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of the study is to assess the efficacy of high-frequency non-invasive ventilation on apnea duration, carbon dioxide clearance and oxygen delivery in healthy subjets and patients with lung disease.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

High frequency ventilation (HF-V) allows to ensure oxygen delivery and carbon dioxide clearance despite the absence of thoracic movement in anesthetized, invasively ventilated subjects. This same technique could be applied by a non-invasive interface (HF-NIV), allowing to obtain a prolonged apnea (absence of thoraco-abdominal respiratory movements) in awaken subjects. Such an application would be of interest for several clinical applications, e.g. lung imaging and radio-therapy treatment on lung cancer. The purpose of the study is to assess the effect of different HF-NIV setting on the apnea duration, carbon dioxide clearance and oxygen delivery in healthy subjets and patients with lung diseases.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Non-invasive Ventilation High-frequency Ventilation Healthy Volunteer Lung Diseases

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Low - High frequence sequence

High-Frequency non-invasive ventilation (HF-NIV) with 2 different settings, sequence of respiratory rate 250/min and respiratory rate 500/min

Group Type EXPERIMENTAL

High-frequency non-invasive ventilation

Intervention Type DEVICE

Comparison of 2 different settings of HF-NIV

High - Low frequence sequence

High-Frequency non-invasive ventilation (HF-NIV) with 2 different settings, sequence of respiratory rate 500/min and respiratory rate 250/min

Group Type EXPERIMENTAL

High-frequency non-invasive ventilation

Intervention Type DEVICE

Comparison of 2 different settings of HF-NIV

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

High-frequency non-invasive ventilation

Comparison of 2 different settings of HF-NIV

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

HF-NIV

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* healthy subjets : normal respiratory function and no known lung disease
* lung disease patients : chronic obstructive pulmonary disease, Sarcoidosis, Cystic fibrosis
* age \>=18y

Exclusion Criteria

* increased pneumothorax risk under positive pressure ventilation
* pregnancy
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre Hospitalier Universitaire Vaudois

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Adam Ogna

MD

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Alban Lovis

Role: PRINCIPAL_INVESTIGATOR

Service de Pneumologie - CHUV

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Service de Pneumologie - Centre Hospitalier Universitaire Vaudois

Lausanne, , Switzerland

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Switzerland

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Alban Lovis, MD

Role: CONTACT

Adam Ogna, MD

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Alban Lovis, MD

Role: primary

Adam Ogna, MD

Role: backup

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ANIV

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.